If Medicare decides to cover the controversial Alzheimer's drug, the price drop could benefit program costs.
from Section Page News - Modern Healthcare https://ift.tt/3peVtwx
Health tips in Tamil and English & more unique news updates too, " Health is wealth " so, Read data and be strong and healthy!!
If Medicare decides to cover the controversial Alzheimer's drug, the price drop could benefit program costs.
Hospital chaplains have a calling to provide spiritual care to patients and their families—as well as staff. But that's not the only critical job they perform.
Oracle wants to purchase Cerner for $95 per share.
For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital. But laboratory testing suggests the drugs will be much less potent against omicron.
Mount Sinai Health System’s emergency departments are seeing about 20% more patients — with all conditions — in recent days, but so far they're seeing more "treat-and-release" coronavirus patients than in earlier waves.
The federal agency separately said there would be no citations of companies regarding its testing requirements before Feb. 9.